Literature DB >> 12220104

Characterization of CD3+ CD4- CD8- (double negative) T cells in patients with systemic lupus erythematosus: production of IL-4.

G S Dean1, A Anand, A Blofeld, D A Isenberg, P M Lydyard.   

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune rheumatic disease that may affect every organ or system in the body. We have shown previously that the TCR alphabeta+ subpopulation of CD3+ CD4- CD8-, DN T cells is expanded in patients with SLE and that double negative T cells express increased levels of activation markers compared both with healthy people and with patients with rheumatoid arthritis, (RA) as autoimmune controls. The aim of this study was to characterize these cells in terms of their ability to produce IL4, a Th2 cytokine, both spontaneously and after mitogen stimulation. It was found that a higher percentage of TCR alphabeta+ double negative T cells from patients with SLE contained IL4 constitutively than did the same population of cells from healthy people or from those with RA. After mitogen stimulation, there was no significant difference in the amount of IL4 produced by each of the three groups. Further study of patients producing high levels of IL4 (about one third of the patients) indicated that they had a lower percentage of alphabeta+ T cells in the double negative compartment than did patients with fewer IL4 containing cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12220104     DOI: 10.1191/0961203302lu234oa

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  17 in total

Review 1.  T cells as therapeutic targets in SLE.

Authors:  José C Crispín; Vasileios C Kyttaris; Cox Terhorst; George C Tsokos
Journal:  Nat Rev Rheumatol       Date:  2010-05-11       Impact factor: 20.543

2.  The DNA methylation signature of human TCRαβ+CD4-CD8- double negative T cells reveals CG demethylation and a unique epigenetic architecture permissive to a broad stimulatory immune response.

Authors:  Paul A Renauer; Patrick Coit; Amr H Sawalha
Journal:  Clin Immunol       Date:  2014-10-29       Impact factor: 3.969

3.  Programmed cell death 1 and Helios distinguish TCR-αβ+ double-negative (CD4-CD8-) T cells that derive from self-reactive CD8 T cells.

Authors:  Noé Rodríguez-Rodríguez; Sokratis A Apostolidis; Pablo Penaloza-MacMaster; José Manuel Martín Villa; Dan H Barouch; George C Tsokos; José C Crispín
Journal:  J Immunol       Date:  2015-03-30       Impact factor: 5.422

4.  Identification of T-cell epitopes on U1A protein in MRL/lpr mice: double-negative T cells are the major responsive cells.

Authors:  Mei-Hui Yang; Jau-Ling Suen; Shiao-Lan Li; Bor-Luen Chiang
Journal:  Immunology       Date:  2005-06       Impact factor: 7.397

Review 5.  The dysregulation of cytokine networks in systemic lupus erythematosus.

Authors:  Sokratis A Apostolidis; Linda A Lieberman; Katalin Kis-Toth; José C Crispín; George C Tsokos
Journal:  J Interferon Cytokine Res       Date:  2011-08-30       Impact factor: 2.607

6.  Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys.

Authors:  José C Crispín; Mohamed Oukka; George Bayliss; Robert A Cohen; Christine A Van Beek; Isaac E Stillman; Vasileios C Kyttaris; Yuang-Taung Juang; George C Tsokos
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

Review 7.  Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS).

Authors:  David T Teachey; Alix E Seif; Stephan A Grupp
Journal:  Br J Haematol       Date:  2009-11-23       Impact factor: 6.998

8.  Targeting Notch signaling in autoimmune and lymphoproliferative disease.

Authors:  David T Teachey; Alix E Seif; Valerie I Brown; Marlo Bruno; Ralph M Bunte; Yueh J Chang; John K Choi; Jonathan D Fish; Junior Hall; Gregor S Reid; Theresa Ryan; Cecilia Sheen; Patrick Zweidler-McKay; Stephan A Grupp
Journal:  Blood       Date:  2007-10-09       Impact factor: 22.113

9.  Inhibition of SHP2 ameliorates the pathogenesis of systemic lupus erythematosus.

Authors:  Jianxun Wang; Masayuki Mizui; Li-Fan Zeng; Roderick Bronson; Michele Finnell; Cox Terhorst; Vasileios C Kyttaris; George C Tsokos; Zhong-Yin Zhang; Maria I Kontaridis
Journal:  J Clin Invest       Date:  2016-05-16       Impact factor: 14.808

10.  Human TCR-alpha beta+ CD4- CD8- T cells can derive from CD8+ T cells and display an inflammatory effector phenotype.

Authors:  José C Crispín; George C Tsokos
Journal:  J Immunol       Date:  2009-09-04       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.